28 episodes

Business Trip tells the story of the emerging industry of psychedelics. Each episode features founders from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem.

Business Trip Greg Kubin & Matias Serebrinsky

    • Business
    • 5.0 • 43 Ratings

Business Trip tells the story of the emerging industry of psychedelics. Each episode features founders from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem.

    Dylan Beynon, CEO of Mindbloom: How ketamine-assisted therapy treats anxiety and depression

    Dylan Beynon, CEO of Mindbloom: How ketamine-assisted therapy treats anxiety and depression

    Today’s episode features Dylan Beynon from Mindbloom, a mental and wellbeing startup that is currently offering ketamine-assisted therapy to treat anxiety and depression. Mindbloom is opening clinics across the country and is using technology to lower the cost of treatment. Host Greg Kubin participates in a ketamine-assisted therapy session in the episode.

    And that ethereal track you hear during the ketamine session is called Happiness Frequency by Conscious Sounds 432hz.

    Created by Greg Kubin and Matias Serebrinsky
    Host: Greg Kubin
    Produced by Jonathan A. Davis & Zack Frank
    Marketing by DaisyMae VanValkenburgh
    Read the transcript here.

    Watch episode 1 on YouTube.

    Music: Sal by Xylo-Ziko, Ocean Waves by Siddhartha Corsus, Sun Heights by Muted Circus, Sita’s Song by Siddhartha Corsus, and Fair Detective by Muted Circus.

    Find us at businesstrip.fm
    Follow us on Instagram and Twitter!

    Find us at businesstrip.fm

    • 31 min
    Building a psychedelic media company: DoubleBlind's Shelby Hartman and Madison Margolin

    Building a psychedelic media company: DoubleBlind's Shelby Hartman and Madison Margolin

    Today’s episode features Shelby Hartman and Madison Margolin from DoubleBlind, a psychedelic magazine and media company founded in 2019 covering timely, untold stories about the expansion of psychedelics around the globe. Focused on how the industry can engage in sacred reciprocity and ethical psychedelic therapies, DoubleBlind is a for-profit company working on becoming a fully licensed certified B corporation.


    Links to topics discussed in this episode:
    What It’s Like to Have Sex on Different Kinds of Psychedelics
    How Oregon is Leading the Country in Drug Policy Reform
    Entheogen: Definition and History
    How Psychedelics are Reigniting Judaism
    Michael Pollan's book How to Change Your Mind
    Ayelet Waldman's book: A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life
    MDMA Testing Kits from DanceSafe

    Read the transcript here.

    Watch episode 2 on YouTube.

    Created by Greg Kubin and Matias Serebrinsky
    Host: Greg Kubin
    Produced by Jonathan A. Davis

    Find us at businesstrip.fm
    Follow us on Instagram and Twitter!

    Theme music by Dorian Love
    Additional music: Plasticity by Blue Dot Sessions


    IsEbOcbXwtgQS6Jzz1Eb

    • 26 min
    How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer

    How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer

    Today's episode features Ryan Zurrer, founder of Vine Ventures, one of the first venture capital funds investing in psychedelic medicine. Ryan has deep roots in psychedelics culture and understands the many cultures within the psychedelic space. His fund is aligned with those values.
    If you’re a founder, investor, or early hire at a psychedelic company, this episode is a must-listen!
    In this episode, we discuss:
    Which psychedelic business models are a good fit for venture capital?Why did Ryan start Vine Ventures?What traits of entrepreneurs does Ryan invest in?Which form of psychedelic medicine is better: natural or synthetic compounds? 
    Links to topics discussed in this episode:
    Pharmauasca
    Oregon Initiative Measure 109
    ENTHEON
    PsyGen
    California Sober
    Atai
    Compass
    Get in touch with Ryan Zurrer - TW: @rzurrer LI: Ryan Zurrer

    Read the transcript here.
    Watch episode 3 on YouTube.
    Created by Greg Kubin and Matias Serebrinsky
    Host: Greg Kubin
    Produced by Jonathan A. Davis


    Find us at businesstrip.fm
    Follow us on Instagram and Twitter!


    Theme music by Dorian Love
    Additional music by Blue Dot Sessions and Chad Crouch

    • 57 min
    Helping psychedelic practitioners through software: Maya Health CEO David Champion

    Helping psychedelic practitioners through software: Maya Health CEO David Champion

    Today's episode features David Champion, CEO and co-founder of Maya, a software platform that helps practitioners and clinics manage psychedelic-assisted therapy practices. The data collected from treatments will help psychedelic stakeholders, from researchers to pharmaceutical companies, discover insights for safer and more effective treatments.
    In this episode, we discuss:
    Removing the guesswork from developing psychedelic therapy protocolsFundraising tips for psychedelic company foundersThe role of data in surfacing safer and more effective treatmentsA big announcement from Matias and Greg!Links to topics discussed in this episode:
    Zendo Project - Subsidiary of MAPS
    Johns Hopkins - Center for Psychedelic and Consciousness Research
    MAPS
    CIIS
    EMR & EHR - What's the difference?


    Read the transcript here.
    Watch episode 4 on YouTube.
    Created by Greg Kubin and Matias Serebrinsky
    Host: Greg Kubin
    Produced by Jonathan A. Davis
    Marketing by DaisyMae VanValkenburgh


    Find us at businesstrip.fm
    Follow us on Instagram and Twitter!


    Theme music by Dorian Love
    Additional music by Blue Dot Sessions.

    • 29 min
    From serving medicine to company founder: NANA founder Flor Bollini

    From serving medicine to company founder: NANA founder Flor Bollini

    Today's episode features Flor Bollini, founder of NANA, an online platform that guides patients on using psychedelic medicine for holistic healing.
    NANA provides personalized protocols based on an assessment of your mental, emotional and physical health. From there you are partnered with a Nana or guide who leads telemedicine therapy that incorporates ketamine, cannabis and CBD.
    Flor hopes these protocols will become best practices for patients, clinics, and the psychedelic medicine ecosystem.
    In this episode, we discuss:
    Why Flor transitioned from serving medicine to company founderDeveloping protocols where the FDA doesn’t regulateThe benefits of progressive dosingHer experiences with 5-MeO-DMT and Iboga. “The Everest of psychedelics” as she calls them.

    Links to topics discussed in this episode:
    UNESCO - United Nations Educational, Scientific and Cultural Organization
    Ifa - Ancient Divination System
    Ayurveda
    Jungian
    5-MeO-DMT
    LMS - Learning Management System
    REM Sleep - Rapid Eye Movement Sleep
    SSRIs - Selective Serotonin Reuptake Inhibitors
    Ayahuasca
    Ibogaine
    Bwiti religion
    Serotonin Syndrome

    Read the transcript here.
    Watch episode 5 on YouTube.
    Created by Greg Kubin and Matias Serebrinsky
    Host: Greg Kubin
    Produced by Jonathan A. Davis
    Marketing by DaisyMae VanValkenburgh


    Find us at businesstrip.fm
    Follow us on Instagram and Twitter!


    Theme music by Dorian Love
    Additional music by Blue Dot Sessions.

    • 33 min
    How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka

    How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka

    Today's episode features Danny Motyka, founder of Psygen, a Canadian manufacturer of psychedelics, like MDMA, LSD, DMT, and synthetic psilocybin.
    Psygen makes pharmaceutical grade psychedelic medicines for clinical research and therapeutic applications. They have a license to be one of the first manufacturing facilities dedicated to the synthesis of psychedelic medicine. 
    In this episode, we discuss:
    Behind the scenes of Psygen’s manufacturing processNatural vs Synthetic psychedelicsNavigating regulations for manufacturing Schedule 1 substancesLinks to topics discussed in this episode:
    GMP
    Dr. Peter van der Heyden
    COMP360
    Entourage Effect
    Health Canada
    Nick Sand - Orange Sunshine
    MDMA, LSD, 5-MeO-DMT, Ibogaine, Psilocybin
    Entheon Biomedical
    MAPS
    2C-B


    Read the transcript here.
    Watch episode 6 on YouTube.
    Created by Greg Kubin and Matias Serebrinsky
    Host: Greg Kubin
    Produced by Jonathan A. Davis & Zack Frank
    Marketing by DaisyMae VanValkenburgh


    Find us at businesstrip.fm
    Follow us on Instagram and Twitter!


    Theme music by Dorian Love
    Additional music by Crystals by Xylo-Ziko, Obscure Train by Revolution Void, Love Chances by Makaih Beats, and Kleptotonic Swing by Tri-Tachyon

    • 30 min

Customer Reviews

5.0 out of 5
43 Ratings

43 Ratings

StacieLeigh89 ,

Intriguing

As a product management leader in fintech looking to pursue meaningful work, this series is exciting, intriguing, and inspiring. The insights from different entrepreneurs in this space give a 360 degree look into the landscape and trends. Thank you for this work!

Annie Dee Bee ,

Making the world a psychedelic therapy user-friendly.

I am someone who uses Mindbloom and ketamine therapy, which has been amazingly useful in helping me with depression and anxiety. Also a little PTSD. I was really excited to see the show, explaining how and why ketamine works so well. I am sending it to a friend who is considering doing ketamine therapy through Mindbloom. This episode really goes into the science behind ketamine and its affect on the brain. really super excited to see the world of psychedelic therapy opening up and I appreciate this podcast for bringing these new businesses to light. I will keep listening avidly. by the way great host! Friendly voice, and really knows how to explain this stuff in a wonderful way. He asked great questions of his interview subjects and I’m learning a lot. Please keep up the good work!

mike c g 123 ,

Favorite psychedelic podcast!

I’m really enjoying the deep dive conversations Greg and Matias are having with leading figures across the psychedelic landscape.

Top Podcasts In Business

Erika Kullberg
Freakonomics Network & Zachary Crockett
Ramsey Network
NPR
Jocko DEFCOR Network
Andy Frisella #100to0

You Might Also Like

Psychedelics Today
MAPS
Numinus
iHeartPodcasts and Protozoa
Sam Harris
Ten Percent Happier